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Invasive bacterial infection in mammals often stimulates a fatal syndrome of
hypotension, organ dysfunction and somatic tissue edema (1). This systemic
response to critical illness in man is associated with somatic cell injury, as
measured by a decrease in skeletal muscle transmembrane potential difference
(Em), increased cellular sodium and water levels, and depletion ofcellular potas-
sium stores (2). These alterations in plasma membrane function are not tempo-
rally related to inadequate tissue perfusion or to depletion of high-energy
phosphate stores (3). To date. no direct mediator for this deterioration ofplasma
membrane and electrolyte homeostasis has been identified.
Recent work (4, 5) has shown that cachectin/tumor necrosis factor (TNF) is
an important mediator ofthe lethal effects ofendotoxin/LPS(6), and isproduced
in large quantities by macrophages exposed to endotoxin (7, 8). High-affinity
receptors for cachectin (7) stimulate altered cellular energy metabolism both in
vivoand in vitro, but theevaluation oftarget tissues thus far has not demonstrated
any adverse influence on normal cell viability. Several host tissues possess cach-
ectin receptors (muscle, adipose, liver) (7) and exhibit extracellular responses at
low receptor occupancy, a characteristic of many systemic mediators.
Since passive immunization against cachectin confers a survival advantage in
endotoxin/LPS-treated animals (6), we hypothesized that this monokine might
affect skeletal muscle plasma membrane function during endotoxemiaandshock.
In this study, we observed that cachectin stimulated skeletal muscle fiber depo-
larization in an isolated muscle model. The plasma membrane response was
prevented by pretreatment of cachectin with specific antibody to cachectin, and
was not due to endotoxin/LPS. Measurement of muscle En, in vivo showed a
similar decline after cachectin infusion .
Recombinant human cachectin was prepared from a yeast expression system by previ-
ously described methods (4) and diluted in Krebs-Ringer-bicarbonate buffer (KRB) to the
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final concentrations indicated for each experiment. A neutralizing mAb (SW18.1) to
human cachectin was prepared in mice and diluted to an initial concentration of 0.5
mg/ml. Cachectin (10 nM/liter) was incubated with mAb (diluted 1 :100) in 3 ml KRB for
1 h at 0°C and i h at 37° C. LPS (E. coli strain 0127:138 ; Difco Laboratories, Detroit, MI)
was diluted to 0 .7 ng/ml in KRB.
In all experiments, we used female Sprague-Dawley rats weighing 175-250 g, and fed
ad libitum. During pentobarbital anesthesia, the extensor digitorum longus and soleus
muscles were excised with the tendons intact. The specimens were quickly transferred to
20-ml vials containing 3 ml KRB, pH 7.40, with insulin 0.1 U/ml, glucose (5 mM), and
chloramphenicol (0.3,ug/ml). The electrolyte content of the medium was: NaCl, 119 mM;
KCI, 5 mM; CaC12, 3 mM ; KH2PO4, I MM; MgS04, 2 mM; NaHCO3, 25 mM . Muscles
were gassed continuously with 95% 02/5% C02 except during measurement ofEm. After
an initial period, which allowed time for cellular recovery and equilibration (30 min),
muscles were transferred to fresh, oxygenated medium, and the basal muscle fiber Em was
recorded at room temperature. Specimens were then transferred to freshly oxygenated
medium containing additives required for each experiment, and Em was again determined.
Membrane potentials were measured with modified Ling-Gerard microelectrodes pre-
pared on a vertical pipette puller from borosilicate glass capillary tubes to a tip diam of
^-0.1 dam. Electrodes were filled with a solution of 3 M KCI, and the tip resistance was
measured. Only those tips with resistance of 5-15 MU were used. During fiber impale-
ments, tip resistance changed by <10%.
The measurement of E, was standardized by the following technique. The microelec-
tode tip was positioned vertically above the muscle, midway between the tendons, with a
Leitz micromanipulator. The electrode was advanced until a superficial fiber was pene-
trated, asjudged by a sharp deflection on the chart recorder. The difference between the
Ag/AgCl reference electrode in the medium and the steady-state recording of potential
for 10 s, free of high-frequency interference, was considered to be the resting membrane
potential of the fiber. The electrode was then advanced until a second fiber was penetrated,
after which the tip was withdrawn and moved laterally. This process was repeated until
membrane potentials were measured in ^-35 individual fibers. No measurement was
rejected on the basis of its absolute magnitude.
Em measurement in vivo was performed on the exposed hindlimb adductor muscles by
previously described methods (3).
Statistical analysis was by Student's paired t test as individual specimens were compared
to the measured, basal recording of Em before the experimental measurement with the
additives indicated.
Results and Discussion
The mean Em for extensor digitorum longus (-70.4 ± 1 .4 mV) and soleus
(-71 .1 ± 1 .0 mV) muscles did not differ significantly, and therefore the results
obtained in those specimens determined under similar conditions were analyzed
together. The muscle Em during basal incubation conditions (-71 .6 ± 1 .0 mV)
agrees closely with previous reports using a similar model (9).
Exposure to cachectin (10 nM/liter) was associated with a decline of muscle
fiber Em (-58 .6 ± 1 .0 mV) that was highly significant (p < 0.001) compared to
the muscle Em of each specimen during basal incubation conditions (Fig. 1).
Experience with this model has demonstrated cell viability for 2 h, as shown by
stable intracellular ATP stores, ability to contract, and maintenance of Em (10).
In agreement with these findings, the basal recordings ofEm varied little through-
out the experimental period (Fig. 1). Cachectin induced significant depolarization
of muscle fiber Em independent of the incubation time. The magnitude of
depolarization initiated by cachectin did not change significantly between incu-
bation intervals. Although we did not determine the precise time required for1370
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FIGURE 1 .
￿
Effect of incubation conditions on transmembrane potential and response to
cachectin. The membrane potentials in muscle fibers were recorded during basal incubation
conditions (open bars) and afterexposure to cachectin (striped bars). Data are the mean ± SE
(mV), calculated on the basis of the number of muscles (n), not on the total number of
impalements (shown in parentheses above bars). The alteration of Em after exposure to
cachectin wassignificant at all time intervals tested (p < 0.001).
cachectin to induce depolarization of individual cells, cellular impalements began
within 5 min after exposure to the monokine, and were completed within 20
min. Thus, the results reflect the acute response of the muscle fiber to cachectin.
The depolarization of muscle E, by cachectin was inhibited by preincubation
of the monokine with a neutralizing mAb (Fig. 2). The ability of cachectin to
affect muscle fiber E, was also lost after heat-denaturation of the monokine.
Under the conditions of our assay, LPS by itself at supraphysiologic concentra-
tions (0 .7 ng/ml) also failed to mediate any alteration of muscle fiber Em.
The addition of cachectin to suspensions of skeletal muscle induced plasma
membrane polarization in a dose-related manner (Fig. 3). A saturating concen-
tration of cachectin (e.g., that concentration required to produce maximal effect)
was acheived at 0.1 nM/liter. Theamount of cachectin that affected Em of muscle
in vitro (>0.01 nM/liter) is comparable to the physiologic levels produced
in vivo after exposure to endotoxin (8). Maximal plasma cachectin activity is
achieved 2 h after endotoxin infusion (8). This response time agrees closely with
the temporal delay of decreased muscle fiber E, in dogs given gram-negative
bacteremia (G . T. Shires, unpublished observation).
After i.v . injection of cachectin in rats, no evidence of tetany or muscle
dysfunction was apparent (11). For 1 h afterinjectionofa lethal dose of cachectin,
animals were ambulatory and breathing normally. However, as Table I indicates,
cachectin mediated a decline in skeletal muscle Em during this time period. The
decrease of cellular Em in vivo may represent the primary signal that initiates the
abnormalities of cellular metabolism following cachectin infusion .TRACEY ET AL.
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FIGURE 2.
￿
Specificity of cachectin-induced depolarization of muscle membranes. Muscles
were incubatedandthen transferred into fresh mediacontainingone of theadditives indicated.
(A) Basal incubation conditions, (B) cachectin (10 nM/liter) (p < 0.001 compared to basal
levels), (C) cachectin pretreated with mAb. Antibody alone diluted 1:100 in KRB did not
exhibit any independent effect on muscle Em (data not shown). (D) Heat-denatured cachectin
(10 nM/liter)(E) LPS(0.7 ng/ml). Data are mean ± SE (mV), presentedas in Fig. 1.
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FIGURE 3.
￿
Estimation of dose/response effect of cachectin on muscle Em. Basal membrane
potentials were measured for 30 muscle specimens, which were then randomly assigned into
one of six groups for exposure to cachectin at the concentrations (nM) shown. Vertical bars
indicate the SE, calculated as in Fig. 1. The differences as compared to paired controls were
significant at concentrations of 0.01 nM (p < 0.05), 0.1 nM (p < 0.05), 1.0 nM (p < 0.001),
and 10 nM (p < 0.001).1372
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TABLE I
Effect of Cachectin on Muscle FiberEm in Vivo
Em
Before
￿
After
0.6
￿
95.0 ± 1.3 (15)*
￿
85.5 ± 1.0 (21)
1.8
￿
93.4 t 0.3 (70)
￿
75.6 ± 1.6 (94)
Cachectin was infused into the vena cava over 20 min. Em was measured before,
and I h after infusion. Data are means ±SE.
* Number of fibers measured.
The effect of cachectin on skeletal muscle plasma membrane function is
particularly interesting because observations ofcritically ill humans have revealed
a depolarization of similar magnitude (2). While the mechanism of this depolar-
ization remains obscure, it may be occurring in othercell types as well, to mediate
the effects of cachectin on cellular metabolism (12, 13). Recent observations'
have shown that cachectin is capable of increasing the rate of glucose uptake and
stimulating lactate production by muscle cells in culture. The present study
suggests that this phenomenon may occur in response to the direct effect of
cachectin on the maintenance of resting Em.
The cachectin-induced change in membrane potential of muscle offers an
explanation for the increased sodium space and fluid retention that occurs in
shock, since 40% of lean body mass would be affected. Moreover, systemic
alterations of host metabolism (metabolic acidosis, hyperkalemia, and elevated
blood lactate levels) may be evoked by the cellular response to this monokine.
The ability of the mAb against cachectin to prevent the reduction of muscle Em
points to its potential utility in the treatment of septic shock.
Summary
Lethal infections are associated with cellular dysfunction as evidenced by a
decrease in the resting transmembrane potential difference (Em) of skeletal
muscle fibers. Endotoxin stimulation of macrophages evokes production of ca-
chectin, a protein that has been implicated as a mediator of the lethal effects of
endotoxemia. In the present study, rat skeletal muscle fiber Em decreased when
incubated with recombinant human cachectin. The reduction of Em induced by
cachectin occurred in a dose-related fashion and was inhibited by mAb against
the monokine. Infusion of cachectin induced a decline of skeletal muscle Em in
vivo, and suggests that cachectin may acutely mediate alterations of skeletal
muscle membrane function after infection.
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